Data / Federal grants / HT942526VRPTRA
DoW Vision, Translational Research Award
Defense Health Agency Contracting Activity - DHACA (Department of Defense) is accepting applications until November 12, 2026. It lists 1 award expected, $1.6 million in total.
SpecStream is the live web data engine for teams and agents. It reads every open and forecast federal opportunity on Grants.gov each morning, and this page is that reading. Describe your organization once and the grants that fit arrive in your sheet, CRM, Slack or agent as they are posted.
Key facts
- Opportunity number
- HT942526VRPTRA
- Status
- Posted, open
- Posted
- May 5, 2026
- Closes
- November 12, 2026
- Expected awards
- 1
- Total funding
- $1,600,000
- Cost sharing
- Not required
- Funding instrument
- Grant
- Category
- Science and Technology and other Research and Development
- Assistance listing
- 12.420 Military Medical Research and Development
- Contact
- Teresa M Parker-Reeser Grants Officer · [email protected] · 3016192171
Who can apply
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
What the agency says
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Translational Research Award (TRA) supports translational research that transforms a promising discovery into new drugs, devices or clinical practice guidelines that are ready for definitive testing in clinical trials during or by the end of the period of performance. The TRA may be used to support preclinical studies, clinical research or a pilot clinical trial , but not a full-scale clinical trial . Research must align with at least one of the FY26 VRP Focus Areas .
Distinctive Features:
· If developing new drugs or device(s), the research team must include expertise in the regulatory approval process.
· The TRA includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs, an Initiating PI and a Partnering PI.
· Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact, Personnel and Post-Award Transition Plan.
· Programmatic review criteria include adherence to the intent of the TRA, contribution to the VRP portfolio, relative impact and relevance to military health.
· The VRP may share FY26 TRA applications and reviews with the National Eye Institute (NEI) for independent funding consideration.
https://cdmrp.health.mil/pubs/press/2026/vrppreann
Other open grants from the Department of Defense
| Opportunity | Status | Closes | Award ceiling | Total funding | Record |
|---|---|---|---|---|---|
| ONR FY27 NOFO for Young Investigator Program N0001426SF004 | Open | Oct 30 | grants.gov | ||
| DoW Bone Marrow Failure, Idea Development Award HT942526BMFRPIDA | Open | Nov 4 | $4,000,000 | grants.gov | |
| DoW Bone Marrow Failure, Investigator-Initiated Research Award HT942526BMFRPIIRA | Open | Nov 4 | $1,250,000 | grants.gov | |
| DoW Bone Marrow Failure, Resource Development Award HT942526BMFRPRDA | Open | Nov 4 | $1,250,000 | grants.gov | |
| DoW Reconstructive Transplant, Concept Award HT942526RTRPCA | Open | Nov 4 | $600,000 | grants.gov | |
| DoW Reconstructive Transplant, Investigator-Initiated Research Award HT942526RTRPIIRA | Open | Nov 4 | $8,000,000 | grants.gov |
All grants open to Anyone (unrestricted) · Everything closing in November 2026
Read from the Grants.gov API, last updated 2026-10-23. The agency's notice on Grants.gov is the official record; check it before you apply.